Trial intelligence / Profile preview

Randomized antiplatelet therapy trial after lower extremity angioplasty in peripheral artery disease

2016-002086-54Phase 4Active

Sponsor
University Medical Center Utrecht
Start
May 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in arteriosclerosis obliterans comparing Aspirin, Aspirin + clopidogrel and Ticagrelor (3 arms). Started May 2018; status: active.

02

Drugs

aspirinclopidogrelticagrelor
03

Conditions

arteriosclerosis obliterans

Beyond the preview

Go deeper on 2016-002086-54.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-002086-54.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call